The value of transgenic models for the study of neurodegenerative diseases

Donald L. Price, Philip C. Wong, Alicja L. Markowska, Michael K. Lee, Gopal Thinakaren, Donald W. Cleveland, Sangram S. Sisodia, David R. Borchelt

Research output: Contribution to journalArticle

46 Scopus citations

Abstract

Transgenic animal models are useful in studying the features of APP- and PS1-linked FAD and SOD1-linked FALS. These models help to investigate the nature of the cellular/biochemical/molecular alterations in neural tissue; the character and evolution of neuronal and/or glial abnormalities; the ways mutant proteins cause damage to neurons; and the biochemical pathways associated with cell death. New technologies will help to define changes in a variety of genes/gene products and the events and conformational changes in mutant proteins that are implicated in pathogenic cascades. It is hoped such study will result in novel treatments for testing in transgenic models that can then be translated into new treatments for human neurodegenerative diseases.

Original languageEnglish (US)
Pages (from-to)179-191
Number of pages13
JournalAnnals of the New York Academy of Sciences
Volume920
DOIs
StatePublished - 2000

Fingerprint Dive into the research topics of 'The value of transgenic models for the study of neurodegenerative diseases'. Together they form a unique fingerprint.

  • Cite this

    Price, D. L., Wong, P. C., Markowska, A. L., Lee, M. K., Thinakaren, G., Cleveland, D. W., Sisodia, S. S., & Borchelt, D. R. (2000). The value of transgenic models for the study of neurodegenerative diseases. Annals of the New York Academy of Sciences, 920, 179-191. https://doi.org/10.1111/j.1749-6632.2000.tb06920.x